+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Swine Vaccines Market by Vaccine Type, Animal Age, Route Of Administration, Packaging Type, End User, Disease Type, Distribution Channel - Global Forecast to 2030- Product Image
Swine Vaccines Market by Vaccine Type, Animal Age, Route Of Administration, Packaging Type, End User, Disease Type, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Swine Vaccines Market by Vaccine Type, Animal Age, Route Of Administration, Packaging Type, End User, Disease Type, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083723
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Swine Vaccines Market grew from USD 1.58 billion in 2024 to USD 1.70 billion in 2025. It is expected to continue growing at a CAGR of 7.63%, reaching USD 2.46 billion by 2030.

Setting the Stage for Advancements in Swine Immunization

The global swine vaccine ecosystem is at a pivotal crossroads, influenced by rapid scientific breakthroughs, evolving animal health priorities, and shifting regulatory frameworks. As pork production intensifies to meet growing demand for animal protein, veterinarians, producers, and suppliers alike face mounting pressure to ensure herd immunity and biosecurity. This report delves into the multifaceted forces shaping immunization strategies, from cutting-edge antigen technologies to nuanced market drivers. It equips decision-makers with an overarching view of the competitive terrain, offering clarity on both challenges and untapped potential. The ensuing analysis sets the foundation for a deeper exploration of landscape transformations, trade policy impacts, and targeted segmentation, illustrating how each element converges to redefine value chains in swine immunoprophylaxis.

Emerging Dynamics Reshaping the Swine Vaccine Market

In recent years, the swine vaccine arena has undergone profound shifts driven by innovations in molecular biology, digital diagnostics, and precision delivery methods. Vaccine developers are increasingly harnessing recombinant platforms to produce antigens that confer broad-spectrum protection with minimal adverse effects. Meanwhile, live attenuated and subunit formulations are being optimized to tackle persistent threats like Porcine Reproductive and Respiratory Syndrome with greater efficacy. Alongside these technological strides, data analytics and blockchain-enabled traceability are reshaping supply chain transparency, enabling stakeholders to monitor cold-chain integrity from manufacturing to farm gate.

At the same time, end-user preferences are evolving as commercial farms and veterinary clinics demand customizable packaging solutions and flexible administration routes. Oral and nasal vaccines are gaining traction as stress-free alternatives to traditional injections, especially in large herds. This convergence of science and user-centric design is fostering an environment where agility and responsiveness define the next generation of swine immunization.

Navigating the Economic Ripple of 2025 U.S. Tariffs

In 2025, sweeping tariff adjustments by the United States introduced a new dimension of complexity to global trade in veterinary pharmaceuticals. The imposition of duties on key vaccine components disrupted established import channels, prompting manufacturers to reassess sourcing strategies and price structures. Constrained by elevated input costs, producers faced the imperative to localize certain production steps or negotiate strategic partnerships to sustain competitive pricing on DNA, inactivated, and recombinant vaccines.

Despite these headwinds, innovative supply-chain solutions emerged rapidly. Select suppliers pivoted toward regional manufacturing hubs to circumvent duties, while collaborative research agreements between domestic and international entities helped stabilize development pipelines. Consequently, although short-term cost pressures reverberated through procurement budgets, the realignment fostered a more resilient and diversified supplier base that stands to benefit market stability in the long term.

Unveiling Critical Segmentation Driving Market Complexity

A nuanced understanding of market segmentation reveals the drivers behind targeted vaccine adoption and R&D prioritization. When examining vaccine type, DNA vaccines underscore the shift toward precision immunology, while inactivated and live attenuated formulations retain traction due to established safety profiles. Recombinant and subunit technologies are carving out niches where cross-protective immunity is paramount, and toxoid vaccines continue to address toxin-mediated pathologies.

Diving into animal age categories, piglets remain the focal point of early-life prophylaxis strategies, and weaners benefit from adaptive dosing regimens designed to bridge maternal antibody gaps. Growers and finishers demand broad-spectrum protection that aligns with production cycles, whereas breeders-whether boars or sows-require bespoke immunization schedules to safeguard reproductive performance and neonatal vitality.

Routes of administration provide critical differentiation. Injection remains the standard for high-potency antigen delivery, yet nasal and oral platforms are gaining prominence for their ease of mass application and reduced stress responses. Packaging innovations complement these modalities, with multi-dose bottles offering cost efficiency, pre-filled syringes ensuring dosing accuracy, and vials serving as versatile formats for small-scale or on-site formulation mixing.

End users exhibit distinct purchasing behaviors that shape market outreach. Commercial farms gravitate toward high-volume contracts and technical support, research institutes prioritize novel antigen research tools, and veterinary clinics and hospitals seek turnkey vaccine portfolios accompanied by training resources. Overlaying these categories, disease-specific segmentation-from classical swine fever to swine influenza-drives vaccine pipelines, as firms calibrate their portfolios to address both endemic pathogens like Mycoplasma pneumonia and emerging threats such as porcine circovirus and PRRS.

Finally, distribution channels form the backbone of market accessibility. Veterinary clinics and hospitals remain foundational conduits for professional administration, while online pharmacies-accessible through company websites or e-commerce platforms-cater to the growing preference for direct procurement. This multiplicity of channels underscores the imperative for manufacturers to adopt omnichannel strategies to maximize outreach and streamline order fulfillment.

Regional Patterns Shaping Global Swine Vaccine Demand

Geographical dynamics exert a profound influence on vaccine development priorities and adoption rates. In the Americas, robust pork export markets and stringent regulatory oversight have accelerated the adoption of next-generation vaccine platforms, supported by substantial public-private funding for disease eradication programs. Meanwhile, Europe, Middle East & Africa presents a heterogeneous landscape: Western European nations lead in vaccine innovation and sustainability initiatives, while emerging markets in the Middle East and Africa focus on scalable, cost-effective solutions to combat both endemic and transboundary diseases.

Across Asia-Pacific, high-density swine populations drive demand for rapid immunization campaigns and digital health monitoring tools. National strategies in several countries prioritize self-sufficiency through local manufacturing incentives and partnerships between multinational and regional players. Collectively, these regional patterns highlight the need for adaptable commercial models that reconcile global best practices with local biosecurity mandates and economic realities.

Strategic Profiles of Leading Innovators in Swine Vaccines

Market leadership is being forged by companies that blend robust R&D pipelines with strategic commercialization tactics. Industry stalwarts have invested heavily in genomic and adjuvant research to enhance vaccine potency, while agile biotechnology firms have differentiated themselves through platform versatility and rapid scale-up capabilities. Cross-sector alliances-linking animal health companies with academic and contract research organizations-have expedited candidate validation and regulatory submission processes.

Moreover, early adopters of digital solutions-ranging from e-learning modules for veterinarians to AI-driven demand forecasting-are redefining customer engagement standards. Firms that integrate value-added services such as cold-chain management consulting and pharmacovigilance frameworks cultivate deeper customer loyalty. This confluence of scientific rigor, operational excellence, and service innovation delineates the competitive frontier, where sustained investment in both core biological assets and ancillary support infrastructure is paramount.

Strategic Roadmap for Industry Leadership and Growth

Industry leaders should prioritize diversified antigen portfolios to hedge against disease volatility and regulatory shifts. By fostering collaborative research with academic institutions, organizations can access cutting-edge technologies and expedite proof-of-concept studies. Strategic localization of manufacturing, coupled with modular production lines, will mitigate trade disruptions and enable rapid scaling in response to outbreak scenarios.

Simultaneously, deploying an omnichannel distribution strategy that harmonizes veterinary professional channels with digital storefronts will expand market reach and optimize inventory turnover. Training programs and subscription-based service models can enhance user proficiency and create recurring revenue streams. To maintain a competitive edge, companies must also invest in data analytics capabilities to track real-world vaccine performance and refine immunization protocols through evidence-based feedback loops.

Rigorous Methodology Underpinning Market Intelligence

This analysis leverages a multi-tiered methodology combining exhaustive secondary research with targeted primary interviews. Comprehensive literature reviews encompassed peer-reviewed journals, regulatory filings, and patent databases to map historical and emerging trends. Complementing desk research, in-depth discussions with industry stakeholders-spanning vaccine developers, distributors, and veterinary practitioners-provided firsthand perspectives on market dynamics and adoption barriers.

Data triangulation techniques ensured analytical rigor, aligning qualitative insights with thematic supply-chain and policy data. A validation layer, comprising editorial reviews by subject-matter experts, guaranteed the accuracy and relevance of findings. This systematic approach underpins the credibility of the insights presented, equipping decision-makers with a robust foundation for strategic planning.

Concluding Perspectives on the Future of Swine Vaccination

The swine vaccine landscape is evolving at an unprecedented pace, shaped by scientific innovation, shifting trade policies, and nuanced demand drivers. As vaccine technologies advance and distribution channels proliferate, stakeholders must remain vigilant in adapting strategies to sustain immunization efficacy and market responsiveness. The interplay of segmentation factors-from antigen type to end-user channel-underscores the complexity of meeting diverse industry requirements.

Ultimately, organizations that embrace agility, foster cross-sector collaboration, and harness data-driven decision-making will be best positioned to capitalize on growth opportunities. By synthesizing technological, regulatory, and commercial imperatives, this report illuminates a path forward for those committed to safeguarding global swine health and driving sustainable value creation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Vaccine Type
    • Dna Vaccine
    • Inactivated Vaccine
    • Live Attenuated Vaccine
    • Recombinant Vaccine
    • Subunit Vaccine
    • Toxoid Vaccine
  • Animal Age
    • Breeders
      • Boars
      • Sows
    • Finishers
    • Growers
    • Piglets
    • Weaners
  • Route Of Administration
    • Injection
    • Nasal
    • Oral
  • Packaging Type
    • Multi Dose Bottle
    • Pre Filled Syringe
    • Vial
  • End User
    • Commercial Farms
    • Research Institutes
    • Veterinary Clinics
    • Veterinary Hospitals
  • Disease Type
    • Classical Swine Fever
    • Erysipelas
    • Mycoplasma Pneumonia
    • Porcine Circovirus
    • Porcine Reproductive And Respiratory Syndrome
    • Swine Influenza
  • Distribution Channel
    • Online Pharmacies
      • Company Websites
      • E Commerce Platforms
    • Veterinary Clinics
    • Veterinary Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim Animal Health GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SAS
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.A.
  • Phibro Animal Health Corporation
  • IDT Biologika GmbH

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Swine Vaccines Market, by Vaccine Type
8.1. Introduction
8.2. Dna Vaccine
8.3. Inactivated Vaccine
8.4. Live Attenuated Vaccine
8.5. Recombinant Vaccine
8.6. Subunit Vaccine
8.7. Toxoid Vaccine
9. Swine Vaccines Market, by Animal Age
9.1. Introduction
9.2. Breeders
9.2.1. Boars
9.2.2. Sows
9.3. Finishers
9.4. Growers
9.5. Piglets
9.6. Weaners
10. Swine Vaccines Market, by Route Of Administration
10.1. Introduction
10.2. Injection
10.3. Nasal
10.4. Oral
11. Swine Vaccines Market, by Packaging Type
11.1. Introduction
11.2. Multi Dose Bottle
11.3. Pre Filled Syringe
11.4. Vial
12. Swine Vaccines Market, by End User
12.1. Introduction
12.2. Commercial Farms
12.3. Research Institutes
12.4. Veterinary Clinics
12.5. Veterinary Hospitals
13. Swine Vaccines Market, by Disease Type
13.1. Introduction
13.2. Classical Swine Fever
13.3. Erysipelas
13.4. Mycoplasma Pneumonia
13.5. Porcine Circovirus
13.6. Porcine Reproductive And Respiratory Syndrome
13.7. Swine Influenza
14. Swine Vaccines Market, by Distribution Channel
14.1. Introduction
14.2. Online Pharmacies
14.2.1. Company Websites
14.2.2. E Commerce Platforms
14.3. Veterinary Clinics
14.4. Veterinary Hospitals
15. Americas Swine Vaccines Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Swine Vaccines Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Swine Vaccines Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Zoetis Inc.
18.3.2. Merck & Co., Inc.
18.3.3. Boehringer Ingelheim Animal Health GmbH
18.3.4. Elanco Animal Health Incorporated
18.3.5. Ceva Santé Animale SAS
18.3.6. Virbac S.A.
18.3.7. Vetoquinol S.A.
18.3.8. HIPRA, S.A.
18.3.9. Phibro Animal Health Corporation
18.3.10. IDT Biologika GmbH
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SWINE VACCINES MARKET MULTI-CURRENCY
FIGURE 2. SWINE VACCINES MARKET MULTI-LANGUAGE
FIGURE 3. SWINE VACCINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 70. CANADA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 71. CANADA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 72. CANADA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. CANADA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 76. CANADA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. CANADA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. MEXICO SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 124. GERMANY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. GERMANY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. FRANCE SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 135. FRANCE SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 136. FRANCE SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. FRANCE SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. FRANCE SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. FRANCE SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 151. ITALY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 152. ITALY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 153. ITALY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 154. ITALY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. ITALY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. ITALY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160. SPAIN SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 162. SPAIN SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 163. SPAIN SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SPAIN SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196. DENMARK SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 197. DENMARK SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 198. DENMARK SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 199. DENMARK SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. DENMARK SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. DENMARK SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 203. DENMARK SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. DENMARK SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. QATAR SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 215. QATAR SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 216. QATAR SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 217. QATAR SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. QATAR SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. QATAR SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 221. QATAR SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. QATAR SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 223. FINLAND SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 225. FINLAND SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 226. FINLAND SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. FINLAND SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. FINLAND SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 230. FINLAND SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. FINLAND SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 250. EGYPT SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 251. EGYPT SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 252. EGYPT SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 253. EGYPT SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. EGYPT SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. EGYPT SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 257. EGYPT SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. EGYPT SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 259. TURKEY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 262. TURKEY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 266. TURKEY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. TURKEY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. NORWAY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 279. NORWAY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 280. NORWAY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. NORWAY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. NORWAY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 284. NORWAY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. NORWAY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 286. POLAND SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 287. POLAND SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 288. POLAND SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 289. POLAND SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. POLAND SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. POLAND SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 293. POLAND SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. POLAND SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 314. CHINA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 315. CHINA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 316. CHINA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 317. CHINA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 318. CHINA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 319. CHINA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. CHINA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 321. CHINA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. CHINA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 323. INDIA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 324. INDIA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 325. INDIA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 326. INDIA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. INDIA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 328. INDIA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. INDIA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 330. INDIA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 331. INDIA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 332. JAPAN SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 333. JAPAN SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 334. JAPAN SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 335. JAPAN SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 336. JAPAN SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 337. JAPAN SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. JAPAN SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 339. JAPAN SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 340. JAPAN SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 343. AUSTRALIA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 344. AUSTRALIA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 345. AUSTRALIA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 346. AUSTRALIA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. AUSTRALIA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 348. AUSTRALIA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 349. AUSTRALIA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2030 (USD MILLION)
TABLE 352. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2030 (USD MILLION)
TABLE 353. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 354. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 355. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 356. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 357. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 358. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES,

Companies Mentioned

The companies profiled in this Swine Vaccines market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim Animal Health GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SAS
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.A.
  • Phibro Animal Health Corporation
  • IDT Biologika GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.46 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Reports

Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Modified/Attenuated Live), By Type (Pseudorabies, Porcine Circovirus Type 2), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Modified/Attenuated Live), By Type (Pseudorabies, Porcine Circovirus Type 2), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Swine Vaccines - Global Strategic Business Report - Product Image

Swine Vaccines - Global Strategic Business Report

  • Report
  • 71 Pages
  • Global
From
Swine Vaccines Market Report 2025 - Product Image

Swine Vaccines Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Porcine Vaccines - Global Strategic Business Report - Product Image

Porcine Vaccines - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From

About the Swine Vaccine Market

The Swine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and production of vaccines for swine. Vaccines are used to protect swine from a variety of diseases, including Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus (PCV), and Classical Swine Fever (CSF). Vaccines are typically administered to swine through injection or oral administration. The Swine Vaccine market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Merck Animal Health, Zoetis, Elanco, Boehringer Ingelheim, and Ceva Sante Animale. These companies offer a range of products, including vaccines for PRRS, PCV, and CSF, as well as other vaccines for swine. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.